38 research outputs found
ΠΠ½Π°Π»ΡΠ· Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ Π±Π°Π·ΠΈ ΠΊΠ»ΡΠ½ΡΡΠ½ΠΎΡ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ° Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ
Herpes viruses are a family of DNA viruses, among them herpes simplex virus is the most common (HSV). An important task of modern medicine is effective and safe pharmacotherapy of viral diseases caused by HSV.Aim. To analyze the range of drugs for the topical application in the pharmacotherapy of HSV at the pharmaceutical market of Ukraine, as well as search the evidence base of acyclovir, the leader of the pharmaceutical market.Materials and methods. The analysis of the range of antiherpetic drugs for the topical application was performed according to the analytical system of the study of the pharmaceutical market of Ukraine βPharmstandardβ by the company βMorionβ. To analyze the clinical efficiency and safety of the antiherpetic drug βAcyclovirβ, the following well-known evidence-based databases were used: Cochrane Library, Trip Database, PubMed, Nice.Results. Antiherpetic drugs for the topical application at the pharmaceutical market of Ukraine for 2016-2018 were quantitatively represented from 17 to 20 TN based on 7 INNs, mainly by foreign manufacturers. Drugs of acyclovir were the most accessible and widely presented at the market. The search for the evidence base of acyclovir for the topical application made it possible to find 7 systematic reviews devoted to the treatment of herpes diseases in the evidence-based medicine databases. Numerous studies have shown that the topical treatment with the acyclovir HSV cream on the lips and in genital herpes is less effective than its systemic application. And the use of acyclovir ointments in the treatment of herpetic keratitis is not inferior in effectiveness to the reference drugs.Β Conclusions. The analysis of systematic reviews and meta-analyses has shown that the topical treatment with the acyclovir HSV cream is less effective than its systemic application. The effectiveness of the use of acyclovir ointments in the treatment of herpetic keratitis has also been proven.ΠΠΈΡΡΡΡ Π³Π΅ΡΠΏΠ΅ΡΠ° β ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²ΠΎ ΠΠΠ-Π²ΠΈΡΡΡΠΎΠ², ΡΡΠ΅Π΄ΠΈ ΠΊΠΎΡΠΎΡΡΡ
Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ Π²ΠΈΡΡΡ ΠΏΡΠΎΡΡΠΎΠ³ΠΎ Π³Π΅ΡΠΏΠ΅ΡΠ° (ΠΠΠ). ΠΠ°ΠΆΠ½ΡΠΌ Π·Π°Π΄Π°Π½ΠΈΠ΅ΠΌ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½Π°Ρ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½Π°Ρ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ Π²ΠΈΡΡΡΠ½ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, Π²ΡΠ·Π²Π°Π½Π½ΡΡ
ΠΠΠ.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. ΠΠ½Π°Π»ΠΈΠ· Π°ΡΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΠ° ΠΠ‘ Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠΠ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΡΠ½ΠΊΠ΅ Π£ΠΊΡΠ°ΠΈΠ½Ρ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΠΎΠΈΡΠΊ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π±Π°Π·Ρ Π»ΠΈΠ΄Π΅ΡΠ° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½ΠΊΠ° β Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ½Π°Π»ΠΈΠ· Π°ΡΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΠ° ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΠ΅Π΄ΡΡΠ² Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½ΠΊΠ° Π£ΠΊΡΠ°ΠΈΠ½Ρ Β«Π€Π°ΡΠΌΡΡΠ°Π½Π΄Π°ΡΡΒ» ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ Β«ΠΠΎΡΠΈΠΎΠ½Β». ΠΠ»Ρ Π°Π½Π°Π»ΠΈΠ·Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΠΠ‘ Β«ΠΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΒ» ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΠ΅ Π±Π°Π·Ρ Π΄Π°Π½Π½ΡΡ
Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ: Cochrane Library, Trip Database, PubMed, Nice.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠΎΡΠΈΠ²ΠΎΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΠ΅Π΄ΡΡΠ²Π° Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΡΠ½ΠΊΠ΅ Π£ΠΊΡΠ°ΠΈΠ½Ρ Π·Π° 2016-2018 Π³Π³. Π±ΡΠ»ΠΈ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΠΎΡ 17 Π΄ΠΎ 20 Π’Π Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ 7 ΠΠΠ Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ ΠΈΠ½ΠΎΡΡΡΠ°Π½Π½ΡΠΌΠΈ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡΠ΅Π»ΡΠΌΠΈ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π΄ΠΎΡΡΡΠΏΠ½ΡΠΌΠΈ ΠΈ ΡΠΈΡΠΎΠΊΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π½ΡΠΌΠΈ Π½Π° ΡΡΠ½ΠΊΠ΅ Π±ΡΠ»ΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ°. ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ ΠΏΠΎΠΈΡΠΊ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π±Π°Π·Ρ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ» ΠΎΠ±Π½Π°ΡΡΠΆΠΈΡΡ Π² Π±Π°Π·Π°Ρ
Π΄Π°Π½Π½ΡΡ
Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ 7 ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠ±Π·ΠΎΡΠΎΠ², ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΡΡ
Π»Π΅ΡΠ΅Π½ΠΈΡ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ. ΠΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ Π½Π°ΡΡΠΆΠ½ΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΊΡΠ΅ΠΌΠ° Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΏΡΠΈ ΠΠΠ Π½Π° Π³ΡΠ±Π°Ρ
ΠΈ ΠΏΡΠΈ Π³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠΌ Π³Π΅ΡΠΏΠ΅ΡΠ΅ ΠΎΠΊΠ°Π·Π°Π»ΠΎΡΡ ΠΌΠ΅Π½Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ, ΡΠ΅ΠΌ Π΅Π³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΏΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΠ° ΠΏΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π½Π΅ ΡΡΡΡΠΏΠ°Π΅Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ.ΠΡΠ²ΠΎΠ΄Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠ±Π·ΠΎΡΠΎΠ² ΠΈ ΠΌΠ΅ΡΠ°-Π°Π½Π°Π»ΠΈΠ·ΠΎΠ² ΠΏΠΎΠΊΠ°Π·Π°Π», ΡΡΠΎ Π½Π°ΡΡΠΆΠ½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΊΡΠ΅ΠΌΠΎΠΌ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΠΠ ΠΎΠΊΠ°Π·Π°Π»ΠΎΡΡ ΠΌΠ΅Π½Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ, ΡΠ΅ΠΌ Π΅Π³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅. Π’Π°ΠΊΠΆΠ΅ Π΄ΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΏΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΠ°.ΠΡΡΡΡΠΈ Π³Π΅ΡΠΏΠ΅ΡΡ β ΡΠΎΠ΄ΠΈΠ½Π° ΠΠΠ-Π²ΡΡΡΡΡΠ², ΡΠ΅ΡΠ΅Π΄ ΡΠΊΠΈΡ
Π½Π°ΠΉΠ±ΡΠ»ΡΡ ΡΠΎΠ·ΠΏΠΎΠ²ΡΡΠ΄ΠΆΠ΅Π½ΠΈΠΉ Π²ΡΡΡΡ ΠΏΡΠΎΡΡΠΎΠ³ΠΎ Π³Π΅ΡΠΏΠ΅ΡΡ (ΠΠΠ). ΠΠ°ΠΆΠ»ΠΈΠ²ΠΈΠΌ Π·Π°Π²Π΄Π°Π½Π½ΡΠΌ ΡΡΡΠ°ΡΠ½ΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ Ρ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½Π° Ρ Π±Π΅Π·ΠΏΠ΅ΡΠ½Π° ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΡΡ Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ Π½Π° ΠΠΠ.ΠΠ΅ΡΠ° Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ β Π°Π½Π°Π»ΡΠ· Π°ΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΡ Π»ΡΠΊΠ°ΡΡΡΠΊΠΈΡ
Π·Π°ΡΠΎΠ±ΡΠ² Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ ΠΏΡΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΡΡ ΠΠΠ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠΌΡ ΡΠΈΠ½ΠΊΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ, Π° ΡΠ°ΠΊΠΎΠΆ Π°Π½Π°Π»ΡΠ· Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ Π±Π°Π·ΠΈ Π»ΡΠ΄Π΅ΡΠ° Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠΌΡ ΡΠΈΠ½ΠΊΡ β Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ.ΠΠ°ΡΠ΅ΡΡΠ°Π»ΠΈ ΡΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΈ. ΠΠ½Π°Π»ΡΠ· Π°ΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΡ ΠΏΡΠΎΡΠΈΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΈΡ
Π·Π°ΡΠΎΠ±ΡΠ² Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π·Π° Π΄Π°Π½ΠΈΠΌΠΈ Π°Π½Π°Π»ΡΡΠΈΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ½ΠΊΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ Β«Π€Π°ΡΠΌΡΡΠ°Π½Π΄Π°ΡΡΒ» ΠΊΠΎΠΌΠΏΠ°Π½ΡΡ Β«ΠΠΎΡΡΠΎΠ½Β». ΠΠ»Ρ Π°Π½Π°Π»ΡΠ·Ρ ΠΊΠ»ΡΠ½ΡΡΠ½ΠΎΡ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ° Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ ΠΏΡΠΎΡΠΈΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΎΠ³ΠΎ Π»ΡΠΊΠ°ΡΡΡΠΊΠΎΠ³ΠΎ Π·Π°ΡΠΎΠ±Ρ Β«ΠΡΠΈΠΊΠ»ΠΎΠ²ΡΡΒ» Π²ΠΈΠΊΠΎΡΠΈΡΡΠΎΠ²ΡΠ²Π°Π»ΠΈ Π²ΡΠ΄ΠΎΠΌΡ Π±Π°Π·ΠΈ Π΄Π°Π½ΠΈΡ
Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ: Cochrane Library, Trip Database, PubMed, Nice.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ. ΠΡΠΎΡΠΈΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈ Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠΌΡ ΡΠΈΠ½ΠΊΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ Π·Π° 2016-2018 ΡΡ. Π±ΡΠ»ΠΈ ΠΊΡΠ»ΡΠΊΡΡΠ½ΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π²ΡΠ΄ 17 Π΄ΠΎ 20 Π’Π Π½Π° ΠΎΡΠ½ΠΎΠ²Ρ 7 ΠΠΠ Π·Π΄Π΅Π±ΡΠ»ΡΡΠΎΠ³ΠΎ ΡΠ½ΠΎΠ·Π΅ΠΌΠ½ΠΈΠΌΠΈ Π²ΠΈΡΠΎΠ±Π½ΠΈΠΊΠ°ΠΌΠΈ. ΠΠ°ΠΉΠ±ΡΠ»ΡΡ Π΄ΠΎΡΡΡΠΏΠ½ΠΈΠΌΠΈ ΡΠ° ΡΠΈΡΠΎΠΊΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠΌΠΈ Π½Π° ΡΠΈΠ½ΠΊΡ Π±ΡΠ»ΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΉ Π°Π½Π°Π»ΡΠ· Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ Π±Π°Π·ΠΈ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ Π΄ΠΎΠ·Π²ΠΎΠ»ΠΈΠ² Π²ΠΈΡΠ²ΠΈΡΠΈ Ρ Π±Π°Π·Π°Ρ
Π΄Π°Π½ΠΈΡ
Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ 7 ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ½ΠΈΡ
ΠΎΠ³Π»ΡΠ΄ΡΠ², ΠΏΡΠΈΡΠ²ΡΡΠ΅Π½ΠΈΡ
Π»ΡΠΊΡΠ²Π°Π½Π½Ρ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΈΡ
Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ. Π§ΠΈΡΠ»Π΅Π½Π½Ρ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π΄ΠΎΠ²Π΅Π»ΠΈ, ΡΠΎ ΠΌΡΡΡΠ΅Π²Π΅ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ ΠΊΡΠ΅ΠΌΠΎΠΌ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΠΠ Π½Π° Π³ΡΠ±Π°Ρ
ΡΠ° ΠΏΡΠΈ Π³Π΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΌΡ Π³Π΅ΡΠΏΠ΅ΡΡ Π²ΠΈΡΠ²ΠΈΠ»ΠΎΡΡ ΠΌΠ΅Π½Ρ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈΠΌ, Π½ΡΠΆ ΠΉΠΎΠ³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½Π΅ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ. ΠΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΏΡΠΈ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΡ Π·Π° Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡΡΡ Π½Π΅ ΠΏΠΎΡΡΡΠΏΠ°Π»ΠΎΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ ΠΏΠΎΡΡΠ²Π½ΡΠ½Π½Ρ. ΠΠΈΡΠ½ΠΎΠ²ΠΊΠΈ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΉ Π°Π½Π°Π»ΡΠ· ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ½ΠΈΡ
ΠΎΠ³Π»ΡΠ΄ΡΠ² ΡΠ° ΠΌΠ΅ΡΠ°-Π°Π½Π°Π»ΡΠ·ΡΠ² ΠΏΠΎΠΊΠ°Π·Π°Π², ΡΠΎ ΠΌΡΡΡΠ΅Π²Π΅ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ ΠΊΡΠ΅ΠΌΠΎΠΌ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΠΠ Π²ΠΈΡΠ²ΠΈΠ»ΠΎΡΡ ΠΌΠ΅Π½Ρ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈΠΌ, Π½ΡΠΆ ΠΉΠΎΠ³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½Π΅ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ. Π’Π°ΠΊΠΎΠΆ Π΄ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡΡΡ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΏΡΠΈ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΡ
On the global Lyapunov reducibility of two-dimensional linear systems with locally integrable coefficients
We show that if a two-dimensional linear nonstationary control system with locally integrable and integrally bounded coefficients is uniformly completely controllable, then the corresponding linear differential system closed with a measurable bounded control linear in the state variables has the property of global Lyapunov reducibility
Design Safety Considerations for Water Cooled Small Modular Reactors Incorporating Lessons Learned from the Fukushima Daiichi Accident
The global future deployment of advanced nuclear reactors for electricity generation depends
primarily on the ability of nuclear industries, utilities and regulatory authorities to further
enhance their reliability and economic competitiveness while satisfying stringent safety requirements. The IAEA has a project to help coordinate Member State efforts in the development and deployment of small and medium sized or small modular reactor (SMR) technology. This project aims simultaneously to facilitate SMR technology developers and potential SMR users, particularly States embarking on a nuclear power programme, in identifying key enabling technologies and enhancing capacity building by resolving issues relevant to deployment, including nuclear reactor safety.
The objective of this publication is to explore common practices for Member States, which will be an essential resource for future development and deployment of SMR technology. The accident at the Fukushima Daiichi nuclear power plant was caused by an unprecedented combination of natural events: a strong earthquake, beyond th
e design basis, followed by a series of tsunamis of heights exceeding the design basis tsunami considered in the flood analysis for the site. Consequently, all the operating nuclear power plants and advanced reactors under development, including SMRs, have been incorporating lessons learned from the accident to assure and enhance the performance of the engineered safety features in coping with such external events.
In response to the Fukushima Daiichi accident, the IAEA established an Action Plan on Nuclear Safety. The preparation of this publication was carried out within the framework of the IAEA Action Plan on effectively utilizing
research and development. The main objective of this publication is to present technology developers and user
s with common considerations, approaches and measures for enhancing the defence in depth and operability of water cooled SMR design concepts to cope with extreme natural hazards. Indicative requirements to prevent such an accident from recurring are also provided for States planning to adopt water cooled SMR designs and technologies.
The IAEA gratefully acknowledges the information on technology and safety aspects provided by SMR design organizations and information regarding technical requirements provided by several Member States. The IAEA officers responsible for this publication were M.H. Subki of the Division of Nuclear Power and M. Kim of the Division of Nuclear Installation Safety
ΠΠ½Π°Π»ΡΠ· Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ Π±Π°Π·ΠΈ ΠΊΠ»ΡΠ½ΡΡΠ½ΠΎΡ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ° Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ
Herpes viruses are a family of DNA viruses, among them herpes simplex virus is the most common (HSV). An important task of modern medicine is effective and safe pharmacotherapy of viral diseases caused by HSV.Aim. To analyze the range of drugs for the topical application in the pharmacotherapy of HSV at the pharmaceutical market of Ukraine, as well as search the evidence base of acyclovir, the leader of the pharmaceutical market.Materials and methods. The analysis of the range of antiherpetic drugs for the topical application was performed according to the analytical system of the study of the pharmaceutical market of Ukraine βPharmstandardβ by the company βMorionβ. To analyze the clinical efficiency and safety of the antiherpetic drug βAcyclovirβ, the following well-known evidence-based databases were used: Cochrane Library, Trip Database, PubMed, Nice.Results. Antiherpetic drugs for the topical application at the pharmaceutical market of Ukraine for 2016-2018 were quantitatively represented from 17 to 20 TN based on 7 INNs, mainly by foreign manufacturers. Drugs of acyclovir were the most accessible and widely presented at the market. The search for the evidence base of acyclovir for the topical application made it possible to find 7 systematic reviews devoted to the treatment of herpes diseases in the evidence-based medicine databases. Numerous studies have shown that the topical treatment with the acyclovir HSV cream on the lips and in genital herpes is less effective than its systemic application. And the use of acyclovir ointments in the treatment of herpetic keratitis is not inferior in effectiveness to the reference drugs.Β Conclusions. The analysis of systematic reviews and meta-analyses has shown that the topical treatment with the acyclovir HSV cream is less effective than its systemic application. The effectiveness of the use of acyclovir ointments in the treatment of herpetic keratitis has also been proven.ΠΠΈΡΡΡΡ Π³Π΅ΡΠΏΠ΅ΡΠ° β ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²ΠΎ ΠΠΠ-Π²ΠΈΡΡΡΠΎΠ², ΡΡΠ΅Π΄ΠΈ ΠΊΠΎΡΠΎΡΡΡ
Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ Π²ΠΈΡΡΡ ΠΏΡΠΎΡΡΠΎΠ³ΠΎ Π³Π΅ΡΠΏΠ΅ΡΠ° (ΠΠΠ). ΠΠ°ΠΆΠ½ΡΠΌ Π·Π°Π΄Π°Π½ΠΈΠ΅ΠΌ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½Π°Ρ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½Π°Ρ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ Π²ΠΈΡΡΡΠ½ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, Π²ΡΠ·Π²Π°Π½Π½ΡΡ
ΠΠΠ.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. ΠΠ½Π°Π»ΠΈΠ· Π°ΡΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΠ° ΠΠ‘ Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠΠ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΡΠ½ΠΊΠ΅ Π£ΠΊΡΠ°ΠΈΠ½Ρ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΠΎΠΈΡΠΊ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π±Π°Π·Ρ Π»ΠΈΠ΄Π΅ΡΠ° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½ΠΊΠ° β Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ½Π°Π»ΠΈΠ· Π°ΡΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΠ° ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΠ΅Π΄ΡΡΠ² Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½ΠΊΠ° Π£ΠΊΡΠ°ΠΈΠ½Ρ Β«Π€Π°ΡΠΌΡΡΠ°Π½Π΄Π°ΡΡΒ» ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ Β«ΠΠΎΡΠΈΠΎΠ½Β». ΠΠ»Ρ Π°Π½Π°Π»ΠΈΠ·Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΠΠ‘ Β«ΠΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΒ» ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΠ΅ Π±Π°Π·Ρ Π΄Π°Π½Π½ΡΡ
Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ: Cochrane Library, Trip Database, PubMed, Nice.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠΎΡΠΈΠ²ΠΎΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΠ΅Π΄ΡΡΠ²Π° Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΡΠ½ΠΊΠ΅ Π£ΠΊΡΠ°ΠΈΠ½Ρ Π·Π° 2016-2018 Π³Π³. Π±ΡΠ»ΠΈ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΠΎΡ 17 Π΄ΠΎ 20 Π’Π Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ 7 ΠΠΠ Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ ΠΈΠ½ΠΎΡΡΡΠ°Π½Π½ΡΠΌΠΈ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡΠ΅Π»ΡΠΌΠΈ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π΄ΠΎΡΡΡΠΏΠ½ΡΠΌΠΈ ΠΈ ΡΠΈΡΠΎΠΊΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π½ΡΠΌΠΈ Π½Π° ΡΡΠ½ΠΊΠ΅ Π±ΡΠ»ΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ°. ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ ΠΏΠΎΠΈΡΠΊ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π±Π°Π·Ρ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ» ΠΎΠ±Π½Π°ΡΡΠΆΠΈΡΡ Π² Π±Π°Π·Π°Ρ
Π΄Π°Π½Π½ΡΡ
Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ 7 ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠ±Π·ΠΎΡΠΎΠ², ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΡΡ
Π»Π΅ΡΠ΅Π½ΠΈΡ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ. ΠΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ Π½Π°ΡΡΠΆΠ½ΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΊΡΠ΅ΠΌΠ° Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΏΡΠΈ ΠΠΠ Π½Π° Π³ΡΠ±Π°Ρ
ΠΈ ΠΏΡΠΈ Π³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠΌ Π³Π΅ΡΠΏΠ΅ΡΠ΅ ΠΎΠΊΠ°Π·Π°Π»ΠΎΡΡ ΠΌΠ΅Π½Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ, ΡΠ΅ΠΌ Π΅Π³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΏΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΠ° ΠΏΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π½Π΅ ΡΡΡΡΠΏΠ°Π΅Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ.ΠΡΠ²ΠΎΠ΄Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠ±Π·ΠΎΡΠΎΠ² ΠΈ ΠΌΠ΅ΡΠ°-Π°Π½Π°Π»ΠΈΠ·ΠΎΠ² ΠΏΠΎΠΊΠ°Π·Π°Π», ΡΡΠΎ Π½Π°ΡΡΠΆΠ½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΊΡΠ΅ΠΌΠΎΠΌ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΠΠ ΠΎΠΊΠ°Π·Π°Π»ΠΎΡΡ ΠΌΠ΅Π½Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ, ΡΠ΅ΠΌ Π΅Π³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅. Π’Π°ΠΊΠΆΠ΅ Π΄ΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΏΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΠ°.ΠΡΡΡΡΠΈ Π³Π΅ΡΠΏΠ΅ΡΡ β ΡΠΎΠ΄ΠΈΠ½Π° ΠΠΠ-Π²ΡΡΡΡΡΠ², ΡΠ΅ΡΠ΅Π΄ ΡΠΊΠΈΡ
Π½Π°ΠΉΠ±ΡΠ»ΡΡ ΡΠΎΠ·ΠΏΠΎΠ²ΡΡΠ΄ΠΆΠ΅Π½ΠΈΠΉ Π²ΡΡΡΡ ΠΏΡΠΎΡΡΠΎΠ³ΠΎ Π³Π΅ΡΠΏΠ΅ΡΡ (ΠΠΠ). ΠΠ°ΠΆΠ»ΠΈΠ²ΠΈΠΌ Π·Π°Π²Π΄Π°Π½Π½ΡΠΌ ΡΡΡΠ°ΡΠ½ΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ Ρ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½Π° Ρ Π±Π΅Π·ΠΏΠ΅ΡΠ½Π° ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΡΡ Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ Π½Π° ΠΠΠ.ΠΠ΅ΡΠ° Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ β Π°Π½Π°Π»ΡΠ· Π°ΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΡ Π»ΡΠΊΠ°ΡΡΡΠΊΠΈΡ
Π·Π°ΡΠΎΠ±ΡΠ² Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ ΠΏΡΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΡΡ ΠΠΠ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠΌΡ ΡΠΈΠ½ΠΊΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ, Π° ΡΠ°ΠΊΠΎΠΆ Π°Π½Π°Π»ΡΠ· Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ Π±Π°Π·ΠΈ Π»ΡΠ΄Π΅ΡΠ° Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠΌΡ ΡΠΈΠ½ΠΊΡ β Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ.ΠΠ°ΡΠ΅ΡΡΠ°Π»ΠΈ ΡΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΈ. ΠΠ½Π°Π»ΡΠ· Π°ΡΠΎΡΡΠΈΠΌΠ΅Π½ΡΡ ΠΏΡΠΎΡΠΈΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΈΡ
Π·Π°ΡΠΎΠ±ΡΠ² Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π·Π° Π΄Π°Π½ΠΈΠΌΠΈ Π°Π½Π°Π»ΡΡΠΈΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ½ΠΊΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ Β«Π€Π°ΡΠΌΡΡΠ°Π½Π΄Π°ΡΡΒ» ΠΊΠΎΠΌΠΏΠ°Π½ΡΡ Β«ΠΠΎΡΡΠΎΠ½Β». ΠΠ»Ρ Π°Π½Π°Π»ΡΠ·Ρ ΠΊΠ»ΡΠ½ΡΡΠ½ΠΎΡ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ° Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ ΠΏΡΠΎΡΠΈΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΎΠ³ΠΎ Π»ΡΠΊΠ°ΡΡΡΠΊΠΎΠ³ΠΎ Π·Π°ΡΠΎΠ±Ρ Β«ΠΡΠΈΠΊΠ»ΠΎΠ²ΡΡΒ» Π²ΠΈΠΊΠΎΡΠΈΡΡΠΎΠ²ΡΠ²Π°Π»ΠΈ Π²ΡΠ΄ΠΎΠΌΡ Π±Π°Π·ΠΈ Π΄Π°Π½ΠΈΡ
Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ: Cochrane Library, Trip Database, PubMed, Nice.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ. ΠΡΠΎΡΠΈΠ³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈ Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ Π½Π° ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ½ΠΎΠΌΡ ΡΠΈΠ½ΠΊΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ Π·Π° 2016-2018 ΡΡ. Π±ΡΠ»ΠΈ ΠΊΡΠ»ΡΠΊΡΡΠ½ΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π²ΡΠ΄ 17 Π΄ΠΎ 20 Π’Π Π½Π° ΠΎΡΠ½ΠΎΠ²Ρ 7 ΠΠΠ Π·Π΄Π΅Π±ΡΠ»ΡΡΠΎΠ³ΠΎ ΡΠ½ΠΎΠ·Π΅ΠΌΠ½ΠΈΠΌΠΈ Π²ΠΈΡΠΎΠ±Π½ΠΈΠΊΠ°ΠΌΠΈ. ΠΠ°ΠΉΠ±ΡΠ»ΡΡ Π΄ΠΎΡΡΡΠΏΠ½ΠΈΠΌΠΈ ΡΠ° ΡΠΈΡΠΎΠΊΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠΌΠΈ Π½Π° ΡΠΈΠ½ΠΊΡ Π±ΡΠ»ΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΉ Π°Π½Π°Π»ΡΠ· Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ Π±Π°Π·ΠΈ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ Π΄Π»Ρ ΠΌΡΡΡΠ΅Π²ΠΎΠ³ΠΎ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ Π΄ΠΎΠ·Π²ΠΎΠ»ΠΈΠ² Π²ΠΈΡΠ²ΠΈΡΠΈ Ρ Π±Π°Π·Π°Ρ
Π΄Π°Π½ΠΈΡ
Π΄ΠΎΠΊΠ°Π·ΠΎΠ²ΠΎΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ 7 ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ½ΠΈΡ
ΠΎΠ³Π»ΡΠ΄ΡΠ², ΠΏΡΠΈΡΠ²ΡΡΠ΅Π½ΠΈΡ
Π»ΡΠΊΡΠ²Π°Π½Π½Ρ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΈΡ
Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ. Π§ΠΈΡΠ»Π΅Π½Π½Ρ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π΄ΠΎΠ²Π΅Π»ΠΈ, ΡΠΎ ΠΌΡΡΡΠ΅Π²Π΅ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ ΠΊΡΠ΅ΠΌΠΎΠΌ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΠΠ Π½Π° Π³ΡΠ±Π°Ρ
ΡΠ° ΠΏΡΠΈ Π³Π΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΌΡ Π³Π΅ΡΠΏΠ΅ΡΡ Π²ΠΈΡΠ²ΠΈΠ»ΠΎΡΡ ΠΌΠ΅Π½Ρ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈΠΌ, Π½ΡΠΆ ΠΉΠΎΠ³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½Π΅ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ. ΠΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΏΡΠΈ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΡ Π·Π° Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡΡΡ Π½Π΅ ΠΏΠΎΡΡΡΠΏΠ°Π»ΠΎΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ ΠΏΠΎΡΡΠ²Π½ΡΠ½Π½Ρ. ΠΠΈΡΠ½ΠΎΠ²ΠΊΠΈ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΉ Π°Π½Π°Π»ΡΠ· ΡΠΈΡΡΠ΅ΠΌΠ°ΡΠΈΡΠ½ΠΈΡ
ΠΎΠ³Π»ΡΠ΄ΡΠ² ΡΠ° ΠΌΠ΅ΡΠ°-Π°Π½Π°Π»ΡΠ·ΡΠ² ΠΏΠΎΠΊΠ°Π·Π°Π², ΡΠΎ ΠΌΡΡΡΠ΅Π²Π΅ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ ΠΊΡΠ΅ΠΌΠΎΠΌ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΠΠ Π²ΠΈΡΠ²ΠΈΠ»ΠΎΡΡ ΠΌΠ΅Π½Ρ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈΠΌ, Π½ΡΠΆ ΠΉΠΎΠ³ΠΎ ΡΠΈΡΡΠ΅ΠΌΠ½Π΅ Π·Π°ΡΡΠΎΡΡΠ²Π°Π½Π½Ρ. Π’Π°ΠΊΠΎΠΆ Π΄ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡΡΡ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΌΠ°Π·Π΅ΠΉ Π°ΡΠΈΠΊΠ»ΠΎΠ²ΡΡΡ ΠΏΡΠΈ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΊΠ΅ΡΠ°ΡΠΈΡΡ